# US 2013/0253194 A1 · PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253194 A1
- Document ID: US20130253194A1
- Status: Published application
- Kind: A1
- Application number: 13/785,355
- Filed: 2013-03-05
- Published: 2013-09-26
- Earliest claimed: 2012-03-09
- Assignees: Lexicon Pharmaceuticals, Inc.
- Inventors: Yingzhi BI; Kenneth Gordon CARSON; Giovanni CIANCHETTA; Michael Alan GREEN; Godwin KUMI; Alan MAIN; Yulian ZHANG; Gregory Glenn ZIPP
- Web page: https://patentgrep.com/patent/US20130253194A1

## CPC

- C07D 487/04: Ortho-condensed systems
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/02: for peripheral neuropathies
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/02: without antiinflammatory effect
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07B 59/002: {Heterocyclic compounds}
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Pyrazolo[1,5-a]pyrimidine-based compounds of the formula: are disclosed, wherein R1, R2 and R3 are defined herein. Compositions comprising the compounds and methods of their use to treat, manage and/or prevent diseases and disorders mediated by mediated by adaptor associated kinase 1 activity are also disclosed.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

A compound of the formula:
or a pharmaceutically acceptable salt thereof, wherein:
X is CH or N;
each R1A is independently OR1C, —N(R1C)R2, —C(O)R1C, —C(O)OR1C, —C(O)N(R1C)2, —N(R1C)C(O)OR1C, cyano, halo, or optionally substituted C1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more R1B;
each R1B is independently —OR1C, —N(R1C)2, —C(O)R1C, —C(O)OR1C, —C(O)N(R1C)2, —N(R1C)C(O)OR1C, cyano or halo;
each R1C is independently hydrogen or optionally substituted C1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more of cyano, halo or hydroxyl;
each R2C is independently ˜OR2D, —N(R2D)2, —C(O)R2D, —C(O)OR2D, —C(O)N(R2D)2, —N(R2D)C(O)OR2D, cyano, halo, or optionally substituted C1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more with one or more amino, cyano, halo, hydroxyl, or R2D;
each R2D is independently hydrogen or optionally substituted C1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more of amino, cyano, halo, hydroxyl; and
m is 0-3.

### Claim 47 (depends on 46)

The compound of claim 46, which is of the formula:

### Claim 48 (depends on 47)

The compound of claim 47, which is of the formula:

### Claim 49 (depends on 47)

The compound of claim 47, which is of the formula:

### Claim 50 (depends on 46)

The compound of claim 46, wherein at least one R1A, is halo.

### Claim 51 (depends on 46)

The compound of claim 46, wherein at least one R1A is —OR1C.

### Claim 52 (depends on 51)

The compound of claim 51, wherein R1C is optionally substituted C1-12 hydrocarbyl.

### Claim 53 (depends on 46)

The compound of any of claim 46, wherein R2C is —C(O)OR2D, —C(O)N(R2D)2, or —N(R2D)C(O)OR2D.

### Claim 54 (depends on 46)

The compound of claim 46, wherein R2C is —C(O)R2D.

### Claim 55 (depends on 53)

The compound of claim 53, wherein each R2D is independently hydrogen or C1-12 hydrocarbyl.

### Claim 56 (depends on 53)

The compound of claim 53, wherein at least one R2D is optionally substituted C1-12 hydrocarbyl, which optional substitution is with one or more of amino, cyano, halo, hydroxyl.

### Claim 57 (depends on 53)

The compound of claim 53, wherein R2D is 2-12-membered heterocarbyl comprising at least one nitrogen atom.

### Claim at position 14

58-63. (canceled)

### Claim 64 (depends on 54)

The compound of claim 54, wherein each R2D is independently hydrogen or hydrocarbyl.

### Claim 65 (depends on 54)

The compound of claim 54, wherein at least one R2D is optionally substituted C1-12 hydrocarbyl, which optional substitution is with one or more of amino, cyano, halo, hydroxyl.

### Claim 66 (depends on 54)

The compound of claim 54, wherein R2D is 2-12-membered heterocarbyl comprising at least one nitrogen atom.
